Imunon, Inc.
Data quality: 83%
IMNN
Nasdaq
Manufacturing
Chemicals
$3.05
▼
$0.08
(-2.65%)
Mkt Cap: 11.95 M
Price
$3.05
Mkt Cap
11.95 M
Day Range
$3.00 — $3.21
52-Week Range
$2.52 — $41.22
Volume
79,382
Open $3.11
50D / 200D Avg
$3.17
3.87% below
50D / 200D Avg
$5.01
39.23% below
Quick Summary
Key Takeaways
Negative free cash flow of -14.18 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-430.02%
Below sector avg (-53.41%)
ROIC-280.21%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio1.73
Interest CoverageN/A
Valuation
PE (TTM)
-0.82
Above sector avg (-1.48)
P/B Ratio2.93
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.8 | -1.5 |
| P/B | 2.9 | 1.6 |
| ROE % | -430.0 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -14.50 M |
| ROE | -430.02% | ROA | -163.08% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -14.18 M |
| ROIC | -280.21% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.73 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 3.06 M | Tangible Book Value | 4.08 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.82 | Forward P/E | N/A |
| P/B Ratio | 2.93 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -118.59% | ||
| Market Cap | 11.95 M | Enterprise Value | 6.70 M |
| Per Share | |||
| EPS (Diluted TTM) | -6.83 | Revenue / Share | N/A |
| FCF / Share | -3.61 | OCF / Share | -3.54 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 97.81% |
| SBC-Adj. FCF | -14.53 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 500,000.0 | 500,000.0 | 500,000.0 |
| Net Income | -14.50 M | -18.62 M | -19.51 M | -35.90 M | -20.77 M |
| EPS (Diluted) | -6.83 | -1.62 | -2.16 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -14.65 M | -19.13 M | -21.03 M | -24.92 M | -21.01 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 7.78 M | 11.64 M | 11.29 M | 11.73 M | 10.62 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | 240,000.0 | 248,000.0 | 731,629.0 | 702,918.0 |
| Interest Expense | — | 197,080.0 | 197,080.0 | 5.03 M | 569,881.0 |
| Income Tax | — | -1.28 M | -1.28 M | -1.57 M | -1.38 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.29 M | 9.72 M | 21.92 M | 43.98 M | 74.05 M |
| Total Liabilities | 5.23 M | 5.47 M | 8.53 M | 14.65 M | 18.25 M |
| Shareholders' Equity | 7.06 M | 4.24 M | 13.39 M | 29.33 M | 55.80 M |
| Total Debt | — | — | — | 5.96 M | 5.85 M |
| Cash & Equivalents | 8.78 M | 5.87 M | 5.84 M | 11.49 M | 19.59 M |
| Current Assets | 10.72 M | 8.01 M | 18.24 M | 37.15 M | 51.95 M |
| Current Liabilities | 4.62 M | 4.79 M | 7.39 M | 10.04 M | 6.77 M |
{"event":"ticker_viewed","properties":{"ticker":"IMNN","listing_kind":"stock","pathname":"/stocks/imnn","exchange":"Nasdaq","country":"US"}}